Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > BVS Bioventus > Detailed Quotes

BVS Bioventus

7.000
-0.070-0.99%
Close 09/30 16:00 ET
7.0000.0000.00%
Post Mkt Price 09/30 16:00 ET
High
7.510
Open
7.070
Turnover
1.44M
Low
6.990
Pre Close
7.070
Volume
198.71K
Market Cap
431.65M
P/E(TTM)
Loss
52wk High
17.530
Shares
61.66M
P/E(Static)
21.54
52wk Low
6.300
Float Cap
206.24M
Bid/Ask %
0.00%
Historical High
19.941
Shs Float
29.46M
Volume Ratio
2.11
Historical Low
6.300
Dividend TTM
--
Div Yield TTM
--
P/B
0.96
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.67%
Amplitude
7.36%
Avg Price
7.252
Lot Size
1
Float Cap
206.24M
Bid/Ask %
0.00%
Historical High
19.941
Shs Float
29.46M
Volume Ratio
2.11
Historical Low
6.300
Dividend TTM
--
P/B
0.96
Dividend LFY
--
Turnover Ratio
0.67%
Amplitude
7.36%
Avg Price
7.252
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.
CEO: Mr. Kenneth M. Reali
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...